Editor's Choice
EDITOR’S PICK
Mechanistic clues from urinary trypsin inhibitor in sepsis research
 
More details
Hide details
1
Institute of Biology, University of Szczecin, Szczecin, Poland
 
2
Center for Experimental Immunology and Immunobiology in Infectious Diseases and Cancer, University of Szczecin, Szczecin, Poland
 
3
Centre of Regenerative Medicine, Medical University of Bialystok, Bialystok, Poland
 
4
Tissue and Cell Bank, Medical University of Bialystok Clinical Hospital, Bialystok, Poland
 
 
Publication date: 2025-08-29
 
 
Cent Eur J Immunol 2025;(2):123
 
REFERENCES (7)
1.
Lelubre C, Vincent JL (2018): Mechanisms and treatment of organ failure in sepsis. Nat Rev Nephrol 14: 417-427.
 
2.
Venet F, Monneret G (2018): Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol 14: 121-137.
 
3.
Giamarellos-Bourboulis EJ, Aschenbrenner AC, Bauer M, et al. (2024): The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat Immunol 25: 19-28.
 
4.
Zhao Y, Li Y, Su M, Cai X (2024): Predictive value of miR-582-5p for onset of sepsis-induced acute kidney injury and its functional role during disease development. Cent Eur J Immunol 49: 383-392.
 
5.
Zhang D, Cheng J, Cao D, Sheng K (2025): Innate immunosenescence and sepsis in the elderly: mechanisms and innate immune modulation strategies. Cent Eur J Immunol 50: 3-10.
 
6.
Hu X, Hu A, Luo Y, et al. (2024): LncRNA HCP5 acts as a potential diagnostic biomarker and attenuates the inflammatory response in neonatal sepsis by targeting miR-138-5p/SIRT1. Cent Eur J Immunol 49: 216-226.
 
7.
Fan H, He X, Tong H, Chen K (2024): Preventive effect of hyperforin on lipopolysaccharide-induced acute kidney injury and inflammation by repressing the NF-κB/miR-21 axis. Cent Eur J Immunol 49: 169-186.
 
eISSN:1644-4124
ISSN:1426-3912
Journals System - logo
Scroll to top